Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.31
Delayed Data
As of Jul 22
 +0.02 / +0.22%
Today’s Change
5.26
Today|||52-Week Range
9.54
+18.30%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close9.29
Today’s open9.28
Day’s range9.21 - 9.38
Volume193,101
Average volume (3 months)455,123
Market cap$718.0M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+104.76%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.37

Competitors

 Today’s
change
Today’s
% change
GNMKGenMark Diagnostics ...+0.25+2.62%
RDNTRadNet Inc+0.04+0.68%
SYRSSyros Pharmaceutical...+0.20+1.78%
NVTAInvitae Corp+0.32+4.13%
Data as of 4:02pm ET, 07/22/2016

Financials

Last reporting dateJuly 18, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers

Search for Jobs